Literature DB >> 2360261

The somatostatin analog octreotide in the management of the secretory diarrhea of the acute intestinal graft-versus-host disease in a patient after bone marrow transplantation.

J A Bianco1, C Higano, J Singer, F R Appelbaum, G B McDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2360261     DOI： 10.1097/00007890-199006000-00040

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

Review 1.  Clinical uses of gut peptides.

Authors:  J Geoghegan; T N Pappas
Journal:  Ann Surg       Date:  1997-02       Impact factor: 12.969

2.  Effect of octreotide on small intestinal motility in HIV-infected patients with chronic refractory diarrhea.

Authors:  P J Neild; D F Evans; F D Castillo; R Newson; E T Yasaki; D L Wingate; B G Gazzard
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

Review 3.  Octreotide in the treatment of refractory diarrhoea and intestinal fistulae.

Authors:  M J Farthing
Journal:  Gut       Date:  1994       Impact factor: 23.059

Review 4.  Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel.

Authors:  A G Harris; T M O'Dorisio; E A Woltering; L B Anthony; F R Burton; R B Geller; J H Grendell; B Levin; J S Redfern
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

5.  Graft-versus-host-like colitis and malignant thymoma.

Authors:  Philip W Lowry; John D Myers; Alex Geller; David G Bostwick; Jonathan E Clain
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.487
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.